EP Patent

EP0396777A1 — Interferon preparation for nasal administration

Assigned to Otsuka Pharmaceutical Co Ltd · Expires 1990-11-14 · 36y expired

What this patent protects

The invention provides preparation for nasal administration which contains a pharmacologically effective amount of interferon and a fatty acid ester of sugar.

USPTO Abstract

The invention provides preparation for nasal administration which contains a pharmacologically effective amount of interferon and a fatty acid ester of sugar.

Drugs covered by this patent

Patent Metadata

Patent number
EP0396777A1
Jurisdiction
EP
Classification
—
Expires
1990-11-14
Drug substance claim
No
Drug product claim
No
Assignee
Otsuka Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.